Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma
Authors perspective and future directions Current evidence supports SGLT2 inhibitors as a core component of contemporary heart failure management because of their consistent reductions in HF hospitalization and cardiovascular death across a broad range of patient populations [8,9,10,11,12,13, 45, 49]
Skip to main content An official website of the United States government Espaol Menu Search Search About Cancer Cancer Types Research Grants & Training News & Events About NCI Home Publications NCI Dictionaries NCI Dictionary of Genetics Terms Publications Patient Education Publications PDQ Fact Sheets NCI Dictionaries Dictionary of Cancer Terms Drug Dictionary Dictionary of Genetics Terms Blogs and Newsletters Health Communications Publications Reports You need to enable JavaScript to run this app.
Each option presents distinct advantages and focuses
.webp)
US$ 26.32
.png)
US$ 28.79
US$ 24.43
US$ 28.46
US$ 20.88
US$ 21.85
US$ 25.84
US$ 21.93
